IVVD Kapitalisasi Akuntansi Invivyd Inc

This daily price chart for Invivyd, Inc. (IVVD) on the GURU.Markets platform illustrates the performance of an asset whose operations rely on developing antibodies to combat COVID-19 within the B2B and B2G segments. The current metric stands at 0.18, while financial stability is constrained by volatile cash flow due to drug promotion expenses. FDA licenses provide business protection, although viral mutations necessitate constant updates to developments.

IVVD Kapitalisasi Buku Invivyd (28.04.2023 - 27.10.2026)

Rincian metrik lan analitis perusahaan Invivyd Corp (IVVD)

- rega lan prakiraan konsensus rega:

Bagan rega Invivyd, Inc.|IVVD - Prakiraan konsensus analis

- data kapitalisasi pasar:

Kapitalisasi pasar Invivyd Inc|IVVD - Nilai Total Perusahaan

- data kapitalisasi buku:

Nilai Buku Saham Invivyd, Inc.|IVVD - Kapitalisasi Buku|Nilai Pasar marang Nilai Buku invivyd.com|IVVD - Total Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal Invivyd, Inc.|IVVD - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Invivyd, Inc.|IVVD - Utang perusahaan|Utang marang nilai buku Invivyd Inc

Pambiji fundamental:IVVD - Invivyd

For Invivyd, Inc., an AI-driven antibody developer, this indicator serves as a measure of the business's real value. The metric is calculated by subtracting all debt obligations from total net assets. The trend in the company's book value of equity allows investors to filter out market noise from fundamental trends. Comparing share prices to this level reveals either hidden undervaluation or financial risks, which is critical for assessing the resilience of the proprietary platform against competition from Big Pharma behemoths.

Analisis pesaing Invivyd, Inc.